2.A.6.2.15 Multidrug efflux pump, MexCD-OprJ (exports β-lactams, fluoroquinolones, tetracycline, macrolides, chloramphenicol, biocides, including levofloxacin, carbenicillin, aztreonam, ceftazidime, cefepime, cefoperazone, piperacillin, erythromycin, azithromycin, chloramphenicol, etc.; Mao et al., 2002). Functions with MexC (MFP) and OprJ (OMF) as indicated above (Mao et al., 2002; Poole, 2008; Lorusso et al. 2022). MexCD-OprJ is one of four primary drug exporters in P. aeruginosa (Lorusso et al. 2022). Collateral sensitivity (CS) is an evolutionary trade-off traditionally
linked to the mutational acquisition of antibiotic resistance (AR) (Hernando-Amado et al. 2023).
However, AR can be temporally induced. Mutational
acquisition of ciprofloxacin resistance leads to robust CS to tobramycin
in pre-existing antibiotic-resistant mutants of Pseudomonas aeruginosa.
Further, the strength of this phenotype is higher when nfxB mutants,
over-producing the efflux pump MexCD-OprJ, are selected. Hernando-Amado et al. 2023 induced
transient nfxB-mediated ciprofloxacin resistance by using the
antiseptic dequalinium chloride. Notably, non-inherited induction of AR
renders transient tobramycin CS in the analyzed antibiotic-resistant
mutants and clinical isolates, including tobramycin-resistant isolates.
Further, by combining tobramycin with dequalinium chloride we drive
these strains to extinction. Our results support that transient CS could
allow the design of new evolutionary strategies to tackle
antibiotic-resistant infections, avoiding the acquisition of AR
mutations on which inherited CS depends (Hernando-Amado et al. 2023). The type of quinolone resistance mechanism is related to the frequency of
MDRP and the risk of MDRP incidence is highly dependent on the
order of exposure to gentamicin and ciprofloxacin (Yasuda et al. 2023).
|
Accession Number: | W6QSL8 |
Protein Name: | Multidrug resistance protein A |
Length: | 390 |
Molecular Weight: | 41164.00 |
Species: | Pseudomonas pseudoalcaligenes (strain CECT 5344) [1182590] |
Number of TMSs: | 1 |
Location1 / Topology2 / Orientation3: |
Cell inner membrane1 / Lipid-anchor2 |
Substrate |
macrolide, fluoroquinolone antibiotic, levofloxacin, ciprofloxacin, chloramphenicol, beta-lactam, cefepime, aztreonam, tetracycline, tobramycin, erythromycin A, carbenicillin, ceftazidime, piperacillin, cefoperazone, azithromycin |
---|
1: MSTIRGRYVF SAVALLAAIG LAGCDKGEQG WGEAPPREVD VLTVKTEPFT VIAELPGRIE
61: PVRVAEVRAR VAGIVLKRTF EEGADVKAGD LLFQIDPAPF KAALSRAQGE LARAEAQLFQ
121: AQATVKRYEP LVKIDAVSKQ DFDVAKAALQ SAQADKRSAQ ASVETARLDL GYAEVRAPIA
181: GRIGRAQVTE GALVGQGEAT LLARIQQLDP VYADFTQPAA DALRLRAAIA DGKVAGAADQ
241: PLSLRVDGTD IESKGTLLFT DISVDRSTGQ IALRGRFDNP QGVLLPGMYV RVLTPQGLNQ
301: NAILVPQRAV QRAADGQASV MLLGEDDTVE VRQVTTGAMH GSRWLIAEGL EAGDKVITSS
361: LAAIKPGAKV VPREEAAAAA NAHAPQSQAQ